Roderick Clifton-Bligh
Royal North Shore Hospital, NSW, Australia
- This delegate is presenting an abstract at this event.
Prof Roderick Clifton-Bligh is Head of the Department of Endocrinology at Royal North Shore Hospital, and conjoint professor in Medicine at the University of Sydney. He has been a clinician researcher since completing a PhD in the genetics of thyroid disorders at the University of Cambridge in 1998. His research focuses on the molecular bases of endocrine neoplasms, including Multiple Endocrine Neoplasia syndromes, thyroid cancer, phaeochromocytoma/paraganglioma syndromes, adrenal cancer, and pituitary neoplasms. He is passionate about teaching and mentoring young physicians and has supervised 14 completed PhDs with six in progress. His work has been recognized by awards from NSW Cancer Institute (2013), Asia-Oceania Thyroid Association (2014) and the Endocrine Society of Australia Outstanding Clinical Practitioner Award (2021).
Presentations this author is a contributor to:
Cystic Pancreatic Lesions in MEN1: A Distinct pNEN Phenotype (#337)
5:30 PM
Roderick Clifton-Bligh
Joint Poster Session
Single cell transcriptomic analysis of BRAF papillary thyroid cancer with and without lymphocytic thyroiditis (#151)
11:30 AM
Sumathy Perampalam
Young Investigator Awards: Gail Risbridger Awards
Active Surveillance of Low-Risk Cancers: Scoping review of Decision Support Tools (#399)
5:30 PM
Eleanor White
Joint Poster Session
Surgical Extent in MEN1-Associated Hyperparathyroidism: Balancing Recurrence, Hypoparathyroidism and Quality of Life (#302)
5:30 PM
Roderick Clifton-Bligh
Joint Poster Session
Thyroid dedifferentiation remodels the tumour ecosystem through cytokine-mediated immune reprogramming (#203)
4:00 PM
Martyn Bullock
ESA Basic Science and Clinical Orals
The usp8 p703h germline mutation impairs 14-3-3 binding in a patient with cushing’s disease (#140)
4:40 PM
Adwoa Sey
ESA Basic Science Orals and Lightning Talks
Genotype–phenotype correlations in SDHx-associated pituitary disease- a case series. (#303)
5:30 PM
Roderick Clifton-Bligh
Joint Poster Session
Balancing efficacy and rebound risk: extending denosumab dosing intervals in low-risk patients (#388)
5:30 PM
Brenda Ta
Joint Poster Session
Living with hypoparathyroidism and working together to overcome it (#229)
8:30 AM
Roderick Clifton-Bligh
Patty Keating
Michele Rayes
Nicholas Love
Patty Keating
Michele Rayes
Nicholas Love
ESA - CaSR5 Joint Symposium | CaSR-5 Session 8: New therapies for hypoparathyroidism